Search

कृत्रिम बुद्धिमत्ता (AI) जागतिक औषध शोध क्षेत्रात आमूलाग्�

India’s first indigenous CRISPR therapy, Birsa-101, signals a decisive shift toward affordable gene-editing solutions for Sickle-cell Disease

AI is transforming global drug discovery. As China races ahead and the US recalibrates, India must harness its talent and data to drive pharma innovat

The US-India biotech collaboration under TRUST is more than a bilateral game; it can help reshape global value chains and promote inclusive, ethical i

One year on, as India’s BioE3 policy lays the groundwork for a US$300 billion bioeconomy, its success hinges on closing gaps in talent, scale-up, an

India’s growing biomedical plastic waste stream remains largely excluded from circular economy planning, particularly in healthcare systems beyond h

लोकसंख्येचे वय जसजसे वाढत जाते, तसतसे देश त्यांचा प्रभाव

As aging populations grow, nations turn to longevity diplomacy—using health policies, biotech, and therapeutics to enhance soft power and global lea

अमेरिकेच्या निर्बंधांनी अनवधानाने चीनला संशोधन व विकास

अमेरिकी प्रतिबंधों ने अनायास ही चीन को अपने अनुसंधान व व�

The US restrictions have inadvertently spurred China to accelerate R&D and innovation, allowing it to challenge Western dominance

एंटीबायोटिक प्रतिकारशक्तीची गुंतागुंतीची समस्या केवळ �

The complex problem of antimicrobial resistance needs to be combated with a coordinated strategy, supported by governmental and cross-sector collabora

The collaboration between space research and biotechnology can both improve the health of space travellers and also aid with new research and innovati

मानसिक आरोग्यविषयक संकटाशी प्रभावीपणे सामना करण्यासाठ�

India must prioritise the development of novel drugs to address the mental health crisis effectively, leveraging its biotechnology and pharmaceutical

There is a growing need to harness miRNA biology to develop new technologies and focus on its translational applications

जैवतंत्रज्ञानाच्या प्रगतीमधली गुंतागुंत आणि संभाव्य ज�

‘आयसीईटी’अंतर्गत बायोसिक्युरिटी आणि बायोसेफ्टी या दोह�

Given the complexity and potential risks associated with the biotechnological advancements, India should establish a dedicated biosecurity agency to a

Enhanced collaboration between the US and India on biosecurity and biosafety under iCET could be highly advantageous

Advancements in biotechnology and accessible dual-use technologies have raised concerns about non-state actors gaining unregulated access to biologica

চিন–রাশিয়া জৈবপ্রযুক্তি সহযোগিতা, যা ফার্মাসিউটিক্যা�

चीनी-रशियन बायोटेक्नॉलॉजीच्या सहकार्यामुळे फार्मास्य�

फार्मास्यूटिकल्स और आर्थिक वृद्धि पर रणनीतिक ज़ोर के बू�

The Sino-Russian biotechnology collaboration, augmented by its strategic focus on pharmaceuticals and economic growth, has called for a global concern

While addressing aspects of the synergy between Artificial Intelligence (AI) and biotechnology, the existing regulatory landscape will need more expli

जैसे जैसे जैव प्रौद्योगिकी का उद्योग विकसित हो रहा है, वै�

As the biotechnology industry evolves, integrating synthetic data and model-based reasoning will remain crucial for addressing complex biological chal

As genetic engineering continues to grow and find more avenues of impact, the need to optimise and regulate this technology will also heighten

अपनी स्थापना के साथ ही जैव प्रौद्योगिकी विभाग ने खुद को स�

As the ecosystem evolves and companies mature, there are dire requirements for the next phase of innovation driven growth.

Since its inception, DBT has been committed to delivering solutions for societal challenges with a focus on Make in India.

Saudi Arabia and the UAE are making strides in biotechnology and digital health, investing heavily in genomics and AI, even as further research capacity and robust data governance remain essential.

Advances in disruptive technologies have enabled scientists to engineer biological systems and create more efficient and sustainable products for a range of purposes. The convergence of artificial intelligence (AI) with biotechnology has contributed to the development of therapeutics and vaccines, helped address food security, aided in generating innovative processes to mitigate the effects of climate change, and expanded the bioeconomy. However,

This brief analyses the regulatory, security and ethical challenges facing states and the international community regarding emerging technologies in biotechnology, focusing on the CRISPR/Cas9 gene editing system and artificial gene synthesis. It highlights the inadequacy of current mechanisms such as export control regimes to regulate these emerging technologies because of a fundamental shift in the nature of challenges posed and an altered globa

Biotechnology is a critical and emerging technology with wide-ranging applications in human medicine, biodefence, nutrition, and the use of bio-based materials. This positions it as a key driver of geopolitical influence and a pillar of global health security, where innovations shape disease surveillance and enable the development of medical countermeasures. Recognising biotechnology as an upcoming frontier in technology competition, the Quad cou

During the COVID-19 pandemic, India contributed to the global response by increasing its vaccine development and health diplomacy efforts, underscoring, among others, its potential as a biotechnology powerhouse. The Government of India continued its effort to make progress in biotechnology research and development in the years after, launching the BioE3 policy in 2024. The BioE3 framework aims to develop a US$300-billion bioeconomy in India by 20

The treatment of mental health disorders is a difficult task due to the highly subjective nature of each case, the varying efficacy of drugs available, and the social stigma associated with mental illness. In India, the treatment gap is steep, but it can be reduced in a number of ways: through concerted efforts by the biotechnology and pharmaceutical industries on novel drug development; by leveraging allied technologies such as data science, art

India’s growing strategic importance as a balance to China in the Indo-Pacific region, as well as convergence between New Delhi and Washington DC about Beijing’s aggressive stance on emerging technology, have resulted in warming relations between the United States (US) and India. Indeed, in recent years, there has been a spur of cooperative agreements between the two sides on domains such as defence technology, 5G, and semiconductors. This br

In the biomedical field, laboratories must ensure biosafety while managing pathogens and microorganisms in order to protect personnel and the broader community against potential leaks and lab-acquired infections. Global standards provide a roadmap for the biosafety of laboratories, underscoring the importance of their design and equipment, personnel training, waste management, and communication in preventing potential biohazards from breaching co

Biological weapons can come from naturally occurring microbes and viruses; but innovations in genomic editing are opening up new, potentially more threatening avenues for their development. These innovations can cause or spread disease or resist known therapeutic approaches. Addressing such threats of biowarfare requires obtaining reliable and informative taxonomies for the pathogens and timely and effective responses. This, in turn, calls for co

The intersection of artificial intelligence (AI) with biotechnology has ushered in a period of innovation in healthcare. The interdisciplinary nature of AI enables it to analyse and interpret large data sets from multiple domains. In the case of the life sciences, AI-biotech convergence holds the potential to alter the landscape of diagnostics, monitoring of disease progression, precision medicine, and prediction of public health threats.

The rapid development of genetic engineering technologies has created multiple opportunities for treating genetic diseases and improving human health. However, genetic engineering technology poses ethical, societal, and security challenges. This brief explores these risks, focusing on those related to genetically modified organisms (GMOs) and the revival of ideologies that consider some races to be “more suitable” than others. The brief also